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The influence of obesity on in-hospital 
clinical outcomes after recanalisation 
of chronic total occlusions 
ABSTRACT
Objectives: Recanalisation of chronic total occlusions (CTOs) in interventional cardiology is one of the 
most challenging and complex procedures. Currently, no data are available about the impact of BMI on 
success rates among CTO patients undergoing percutaneous coronary intervention. The aim of this study 
was to investigate the impact that BMI has on success rates, complications, and procedure characteristics 
among a large group of CTO patients who underwent percutaneous coronary intervention.
Methods: The present study retrospectively included 420 patients who underwent percutaneous coronary 
intervention for at least to one chronic total occlusion. Patients were subdivided into groups according to their 
BMI. BMI groups were based on the World Health Organization's definitions: From 18.5 to 24.9 kg/m2 = Normal 
weight; From 25 to 29.9 kg/m2 = Overweight; From 30 to 34.9 kg/m2 = Obesity; Greater than or equal to 
35 kg/m2 = Very obese. In order to subdivide the patients according to the complexity of the CTO-PCI, 
the Japanese-CTO (J-CTO) score was used prior to the interventions. Statistical analyses were performed 
using the SPSS 20.0 software. The value of p < 0.05 was considered as statistically significant.
Results: There was a significant difference in procedure duration, volume of used contrast medium and other 
procedural characteristics in higher BMI categories. There was no statistically significant difference across all 
body mass index categories in terms of procedure success, complication rates, and outcomes (p > 0.05). 
Conclusion: This retrospective study indicates that BMI has no impact on in-hospital outcomes in patients 
with chronic total occlusion after percutaneous coronary intervention.
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Introduction
Recanalisation of chronic total occlusions (CTOs) 
in interventional cardiology is one of the most chal-
lenging and complex procedures [1]. Coronary artery 
CTOs can be identified in around one in every five 
patients who show clinical indications for coronary 
angiography [2]. Recanalisation of CTOs is indicated 
in cases of progressing angina symptoms, with evi-
dence of significant myocardial ischaemia [3]. After 
recanalisation in these patients, an increase in left 
ventricular function can be expected [4]. Due to the 
emerging methods in interventional cardiology and 
the use of new CTO equipment, CTO recanalisation 
success rates have increased steadily in recent years 
[5]. Moreover, coronary artery bypass grafts (CABG) 
can be avoided, which can result in lower complica-
tion rates [6]. 
Worldwide obesity levels have increased in recent 
decades [7]. Obesity and, in particular, severe obesity 
are linked to a heightened risk of cardiovascular dis-
ease (CVD) [8] because BMI is a strong predictor of 
cardiovascular mortality [9]. 
Despite the heightened risks, the in-hospital out-
comes after CTO percutaneous coronary interventions 
(PCI) remain unstudied in this population. Accordingly, 
this study retrospectively evaluates the impact of BMI on 
success and complication rates, as well as procedure 
characteristics among a large group of CTO patients 
undergoing PCI.




A total of 420 patients who underwent CTO-PCI at 
the Lithuanian University of Health Sciences of Kaunas 
were included in this study. Criteria for inclusion were 
a positive test for angina pectoris and/or positive result 
for functional ischaemia from a stress echocardiography 
or magnetic resonance imaging test. Patients were 
subdivided into groups according to their BMI. BMI 
groups were based on the World Health Organisation’s 
definitions [10]:
 — From 18.5 to 24.9 kg/m2 = Normal weight 
 — From 25 to 29.9 kg/m2 = Overweight 
 — From 30 to 34.9 kg/m2 = Obesity 
 — Greater than or equal to 35 kg/m2 = Very obese 
CTO-PCI procedure
Either radial or femoral access was chosen ac-
cording to operator choice. The diameter of guiding 
catheters was either 6 or 7F. Heparin was administered 
at the start of interventions, guided by a clotting time of 
greater than 300 seconds, in order to prevent throm-
boembolic complications. All PCIs were performed via 
anterograde approach. In most cases, dual injections 
were made to define the length of the lesion and for 
the conformation that the PCI guide wire is in the true 
lumen. In case of femoral access, the puncture site was 
sealed using manual compression or various vascular 
closure devices. 
Coronary wires ranged from tapered polymer soft-
tip guide wires at the start to super-stiff guide wires at 
the end. In almost all cases, drug-eluting stents were 
implanted in the occluded segments. Stent apposition 
and expansion was optimised by post-dilatation. 
In order to subdivide the patients according to the 
complexity of the CTO-PCI, the Japanese-CTO (J-CTO) 
score was used prior to the interventions [11]. This 
combined the following parameters:
 — Lesion classification degree.
 — Bending in excess of 45 degrees in the CTO seg-
ment.
 — Blunt proximal cap.
 — Occluded segment length (> 20 mm).
 — Previously failed recanalisation.
The definition of success in the procedure was a res-
toration of TIMI grade 3 flow and recanalisation of CTO. 
Each patient undergoing the procedure had a compos-
ite safety endpoint evaluation. This summarised severe 
complications including stroke, cardiac tamponade, 
vascular complications, or in-hospital death.
Statistical analysis
Continuous variables are shown as median, 
mean ± standard deviation, and minimum–maximum. 
Category variables are presented as percentages 
and frequencies. Normal distribution was tested for 
using the Shapiro-Wilk test. Mann-Whitney U test or 
the Kruskal-Wallis test were used as appropriate for 
continuous variables and the Fisher exact test for cat-
egorical variables.
This study was given approval by the Research Eth-
ics Committee of the Government of Kaunas (Lithuania). 
The study complies with the principles laid down in 
the Declaration of Helsinki, adopted by the 18th World 
Medical Assembly, Helsinki, Finland in June 1964 and 
recently amended at the 59th World Medical Assembly, 
Seoul, Korea in October 2008.
Results
Demographics 
Males (62%) made up the majority of patients, with 
a mean age of 68 years (± 5.4 years). Male patients 
were younger than female patients (67 ± 7.1 years 
vs. 72.2 ± 4.4 years; p < 0.001).   Mean BMI was 
26.8 kg/m2 (± 6.5 kg/m2). From the 420 patients the 
following BMIs were recorded:
 — Normal weight – 42 (10%)
 — Overweight – 252 (60%)
 — Obese – 100 (23.8%)
 — Very obese – 26 (6.2%)
Risk factors 
There was a positive correlation between rising 
BMI categories and cardiovascular risk elements 
such as arterial hypertension, diabetes mellitus, and 
family history of coronary artery disease. Compared 
to patients with a BMI greater than 25 kg/m2, patients 
with normal weight showed higher HDL cholesterol 
(p < 0.05) and lower triglycerides (p < 0.05). Very 
obese patients had a higher incidence of diabetes 
mellitus compared to other subgroups (p = 0.015). 
Overweight patients had a higher rate of chronic 
obstructive pulmonary disease and lower peripheral 
arterial disease prevalence.
Procedural characteristics 
Procedural and CTO characteristics are displayed in 
Table 1. All BMI categories had a similar J-CTO score 
(p > 0.05). The amount of contrast medium used in-
creased as the BMI increased (p = 0.012). The fluoros-
copy time tended to increase proportionally with rising 
BMI (p = 0.03). Procedure duration of normal patients 
was lower as compared to patients with non-normal 
BMIs (p = 0.024). Success rates were similar across all 
BMI categories (p = 0.622; Fig. 1). 













Normal Overweight Obese Very obese
Success
Figure 1. Percentage of success depending on BMI
Table 1. Procedural and angiographic characteristics
Normal Overweight Obese Very obese P
CTO in LAD 28.6 % (12) 28.6 % (72) 32 % (32) 34 % (9) 0.65
CTO in LCX 23.8 % (10) 31.7 % (80) 18 % (18) 27 % (7)
CTO in RCA 47.6 % (20) 39.7 % (100) 50 % (50) 38.5 % (10)
1-vessel disease 26.2 % (11) 20.7 % (52) 35 % (35) 26.9 % (7) 0.84
2-vessel disease 28.6 % (12) 31.7 % (80) 29 % (29) 26.9 % (7)
3-vessel disease 45.2 % (19) 47.6 % (120) 36 % (36) 46.2 % (12)
J-CTO score ≥ 3 59.5 % (25) 65 %  (164) 63 % (63) 57.7 % (15) 0.58
Amount of contrast (ml) 220 (80–320) 260 (100–500) 290 (120–650) 350 (200–800) 0.012
Procedure time (min) 60.5 (30–109) 126.1 (60–190) 160.7 (60–230) 190.2 (90–260) 0.024
Fluoroscopy time (min) 25.6 (6–40) 30.1 (12–60) 35.4 (15–94) 40.2 (20–95) 0.03
Complication rates
There was no statistically significant difference 
in procedural complications, which rarely occurred 
(p = 0.12). There were no acute skin lesions witnessed 
as radiation doses increased with higher BMI categories 
(p < 0.001). The complications that did occur were mostly 
vascular. In three cases cardiac tamponade occurred. Sim-
ilarly, three patients were diagnosed with acute stroke after 
CTO-PCI. No in-hospital deaths were recorded (Fig. 2).
Discussion
The study highlights some important aspects. First-
ly, successful procedures and complications in the hos-
pital proved to be independent of BMI categories. This 
finding seems quite remarkable, given that we are 
already aware of overweight and obese patients from 




















Figure 2. In-hospital outcomes
a wound infection following CABG [12]. This suggests 
that CTO-PCIs might be a safer alternative to CABG in 
very obese patients.
Secondly, patients in higher BMI categories had an 
increase in prevalence of cardiovascular risk factors, 
such as arterial hypertension, diabetes mellitus, dyslipi-
daemia, triglyceride, and HDL-cholesterol levels. These 
co-morbidities are related to the metabolic syndrome 
and are in line with current literature on the subject [13]. 
Thirdly, there was a significant difference in the 
procedure duration, volume of used contrast medium, 
and other procedural characteristics in higher BMI cat-
egories. Obese patients had higher doses of radiation 
(p < 0.001) and longer procedure times (p = 0.026). 
Dermal ulcerations could be a serious consequence 
of such procedures, although there are no supporting 
data from our study due to the short follow-up period. 
Nevertheless, it has been proven by Lia et al. that dermal 
ulcerations can occur during PCIs, especially in CTOs 
because there is an increase of these lesions with higher 
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radiation doses [14]. Thus, given a longer follow-up 
period, higher radiation-associated complication rates 
could be expected in obese patients.
There are divergent opinions on the relationship be-
tween BMI and outcomes in CAD patients. The ‘obesity 
paradox’ is that despite obesity being a strong CVD 
development risk factor, mortality rates for obese and 
very obese patients are low. One possible reason for 
this paradox is that obese patients may be observed 
more and therefore receive faster medical intervention. 
Also, obese patients tend to be younger when the acute 
cardiovascular event occurs. This could imply that there 
is benefit regarding age [15].
A Korean study published in 2012 revealed that the 
relation between BMI and mortality was U-shaped, with 
the nadir among overweight or obese patients, and 
underweight and normal-weight patients having the 
highest risk [16]. Their definition of obese, however, 
was a BMI greater than 25 kg/m2, not 30 kg/m2, as in 
our study. Also, half of the patients in their study had first 
generation drug-eluting stents (DES) implanted. In the 
long term, overweight patients, particularly men, had a re-
duced mortality rate after CTO-PCI, according to a study 
conducted in the USA in 2010 [17]. The patients in their 
study, however, were older than those in our study.
Contrasting trials, in line with our own, have failed to 
indicate a relationship between BMI and PCI survival. 
For instance, data presented from over 5000 patients 
led Diletti et al. to conclude that, following coronary ar-
tery interventions, BMI had no impact on the long-term 
clinical outcomes [18].
Another method of treatment considered as a sub-
stitute for CTO patients could be CABG. Some data 
indicate that mortality was not increased by obesity in 
the short-term perspective; however, this is associated 
with an increase in late mortality rates. [19].
We can demonstrate that there is no dependence 
between in-hospital clinical events and BMI. This is in 
contrast to previous data that suggested that very obese 
and lean patients are at greater risk following PCI [20].
Conclusion
Our ex post facto study indicates that obesity has 
no impact on in-hospital outcomes in CTO-PCI patients.
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